APA (7th ed.) Citation

L, W., A, P., SK, A., R, S., SA, G., & LH, H. (2026). Primary cilia promote resistance to EGFR tyrosine kinase inhibitor, osimertinib, in non-small cell lung cancer. BioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.03.03.709408

Chicago Style (17th ed.) Citation

L, Wang, Pandit A, Alam SK, Skauge R, Gradilone SA, and Hoeppner LH. "Primary Cilia Promote Resistance to EGFR Tyrosine Kinase Inhibitor, Osimertinib, in Non-small Cell Lung Cancer." BioRxiv : The Preprint Server for Biology 2026. https://doi.org/10.64898/2026.03.03.709408.

MLA (9th ed.) Citation

L, Wang, et al. "Primary Cilia Promote Resistance to EGFR Tyrosine Kinase Inhibitor, Osimertinib, in Non-small Cell Lung Cancer." BioRxiv : The Preprint Server for Biology, 2026, https://doi.org/10.64898/2026.03.03.709408.